To further confirm the key role of CTR1 in the synergistic effect of β-elemene with oxaliplatin, we generated two CTR1-specific siRNAs to silence the endogenous CTR1 (si-hCTR1) of HCC cells to observe the different response of HCC cells to the regimen. Here, SLC31A1 is linked to hepatocellular carcinoma.